sample_id stringlengths 11 11 | clinical_text stringlengths 18 347 | category stringclasses 5
values | subcategory stringclasses 20
values | difficulty stringclasses 4
values | drug_mentions listlengths 1 14 | regimen_mentions listlengths 0 2 | num_drugs int64 1 8 | note_type stringclasses 10
values |
|---|---|---|---|---|---|---|---|---|
ONCORX-0254 | Dose: Bortezomib 1.3 mg/m2 SC. Verify with pharmacy. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Bortezomib",
"drug_normalized": "Bortezomib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1.3",
"dose_unit": "mg/m2",
"route": "SC"
},
"start_cha... | [] | 1 | chemo_order |
ONCORX-0255 | Treatment initiated: Decitabine 20 mg/m2 IV days 1-5 q4w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Decitabine",
"drug_normalized": "Decitabine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "20",
"dose_unit": "mg/m2",
"route": "IV",
"frequency": "d... | [] | 1 | chemo_order |
ONCORX-0258 | Plan: Etoposide 100 mg/m2 PO days 1-3 q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Etoposide",
"drug_normalized": "Etoposide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "100",
"dose_unit": "mg/m2",
"route": "PO",
"frequency": "da... | [] | 1 | chemo_order |
ONCORX-0260 | Adjusted Letrozole to 2.5 mg PO daily. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Letrozole",
"drug_normalized": "Letrozole",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "2.5",
"dose_unit": "mg",
"route": "PO",
"frequency": "daily... | [] | 1 | chemo_order |
ONCORX-0262 | Treatment initiated: Letrozole 2.5 mg PO daily. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Letrozole",
"drug_normalized": "Letrozole",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "2.5",
"dose_unit": "mg",
"route": "PO",
"frequency": "daily... | [] | 1 | pharmacy_order |
ONCORX-0263 | Order: Filgrastim 480 mcg SC daily x 7-10 days. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Filgrastim",
"drug_normalized": "Filgrastim",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "480",
"dose_unit": "mcg",
"route": "SC",
"frequency": "da... | [] | 1 | treatment_plan |
ONCORX-0266 | Started Anastrozole 1 mg PO per protocol. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Anastrozole",
"drug_normalized": "Anastrozole",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1",
"dose_unit": "mg",
"route": "PO"
},
"start_char":... | [] | 1 | treatment_plan |
ONCORX-0267 | Rx: Sunitinib 50 mg PO daily x 28 days q6w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Sunitinib",
"drug_normalized": "Sunitinib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "50",
"dose_unit": "mg",
"route": "PO",
"frequency": "daily ... | [] | 1 | treatment_plan |
ONCORX-0268 | Patient receiving Morphine 4 mg IV q4h. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Morphine",
"drug_normalized": "Morphine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "4",
"dose_unit": "mg",
"route": "IV",
"frequency": "q4h"
... | [] | 1 | treatment_plan |
ONCORX-0269 | Patient received Imatinib 400 mg PO without adverse reaction. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Imatinib",
"drug_normalized": "Imatinib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "400",
"dose_unit": "mg",
"route": "PO"
},
"start_char": 17,... | [] | 1 | chemo_order |
ONCORX-0270 | Infuse Azacitidine 75 mg/m2 IV over 60 minutes. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Azacitidine",
"drug_normalized": "Azacitidine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "75",
"dose_unit": "mg/m2",
"route": "IV"
},
"start_ch... | [] | 1 | treatment_plan |
ONCORX-0272 | Plan: Pembrolizumab 2 mg/kg IV q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Pembrolizumab",
"drug_normalized": "Pembrolizumab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "2",
"dose_unit": "mg/kg",
"route": "IV",
"frequency... | [] | 1 | treatment_plan |
ONCORX-0273 | Administer Paclitaxel 80 mg/m2 IV. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Paclitaxel",
"drug_normalized": "Paclitaxel",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "80",
"dose_unit": "mg/m2",
"route": "IV"
},
"start_char... | [] | 1 | pharmacy_order |
ONCORX-0275 | Order: Acetaminophen 500 mg IV q6h. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Acetaminophen",
"drug_normalized": "Acetaminophen",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "500",
"dose_unit": "mg",
"route": "IV",
"frequency"... | [] | 1 | pharmacy_order |
ONCORX-0276 | Increase Gabapentin to 300 mg PO q8h. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Gabapentin",
"drug_normalized": "Gabapentin",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "300",
"dose_unit": "mg",
"route": "PO",
"frequency": "q8h... | [] | 1 | pharmacy_order |
ONCORX-0277 | Administer Metoclopramide 10 mg PO. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Metoclopramide",
"drug_normalized": "Metoclopramide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "10",
"dose_unit": "mg",
"route": "PO"
},
"start... | [] | 1 | treatment_plan |
ONCORX-0278 | Pre-medications followed by Vincristine 2 mg IV. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Vincristine",
"drug_normalized": "Vincristine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "2",
"dose_unit": "mg",
"route": "IV"
},
"start_char":... | [] | 1 | chemo_order |
ONCORX-0279 | Diphenhydramine 50 mg given IV today. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Diphenhydramine",
"drug_normalized": "Diphenhydramine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "50",
"dose_unit": "mg",
"route": "IV"
},
"sta... | [] | 1 | treatment_plan |
ONCORX-0280 | Administer Abiraterone 1000 mg PO. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Abiraterone",
"drug_normalized": "Abiraterone",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1000",
"dose_unit": "mg",
"route": "PO"
},
"start_cha... | [] | 1 | pharmacy_order |
ONCORX-0281 | Dose: Fluorouracil 1000 mg/m2/day IV. Verify with pharmacy. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Fluorouracil",
"drug_normalized": "Fluorouracil",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1000",
"dose_unit": "mg/m2/day",
"route": "IV"
},
"... | [] | 1 | treatment_plan |
ONCORX-0282 | Started Doxorubicin 50 mg/m2 IV per protocol. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Doxorubicin",
"drug_normalized": "Doxorubicin",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "50",
"dose_unit": "mg/m2",
"route": "IV"
},
"start_ch... | [] | 1 | pharmacy_order |
ONCORX-0283 | Pre-medications followed by Bleomycin 10 units/m2 IV. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Bleomycin",
"drug_normalized": "Bleomycin",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "10",
"dose_unit": "units/m2",
"route": "IV"
},
"start_cha... | [] | 1 | pharmacy_order |
ONCORX-0284 | Pegfilgrastim 6 mg given SC today. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Pegfilgrastim",
"drug_normalized": "Pegfilgrastim",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "6",
"dose_unit": "mg",
"route": "SC"
},
"start_ch... | [] | 1 | chemo_order |
ONCORX-0285 | Treatment initiated: Metoclopramide 10 mg IV q6h. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Metoclopramide",
"drug_normalized": "Metoclopramide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "10",
"dose_unit": "mg",
"route": "IV",
"frequency... | [] | 1 | chemo_order |
ONCORX-0286 | Infuse Nivolumab 3 mg/kg IV over 60 minutes. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Nivolumab",
"drug_normalized": "Nivolumab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "3",
"dose_unit": "mg/kg",
"route": "IV"
},
"start_char": ... | [] | 1 | pharmacy_order |
ONCORX-0287 | Patient receiving Paclitaxel 135 mg/m2 IV day 1 q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Paclitaxel",
"drug_normalized": "Paclitaxel",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "135",
"dose_unit": "mg/m2",
"route": "IV",
"frequency": "... | [] | 1 | treatment_plan |
ONCORX-0288 | Oxaliplatin 85 mg/m2 IV q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Oxaliplatin",
"drug_normalized": "Oxaliplatin",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "85",
"dose_unit": "mg/m2",
"route": "IV",
"frequency": ... | [] | 1 | treatment_plan |
ONCORX-0291 | Adjusted Loperamide to 4 mg PO q4h. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Loperamide",
"drug_normalized": "Loperamide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "4",
"dose_unit": "mg",
"route": "PO",
"frequency": "q4h"
... | [] | 1 | pharmacy_order |
ONCORX-0292 | Administer Prochlorperazine 10 mg PO. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Prochlorperazine",
"drug_normalized": "Prochlorperazine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "10",
"dose_unit": "mg",
"route": "PO"
},
"s... | [] | 1 | chemo_order |
ONCORX-0293 | Administer Rituximab 375 mg/m2 IV. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Rituximab",
"drug_normalized": "Rituximab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "375",
"dose_unit": "mg/m2",
"route": "IV"
},
"start_char"... | [] | 1 | pharmacy_order |
ONCORX-0294 | Patient taking Abiraterone 1000 mg PO daily at home. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Abiraterone",
"drug_normalized": "Abiraterone",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1000",
"dose_unit": "mg",
"route": "PO",
"frequency": "... | [] | 1 | treatment_plan |
ONCORX-0295 | Patient received Prochlorperazine 10 mg PR without adverse reaction. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Prochlorperazine",
"drug_normalized": "Prochlorperazine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "10",
"dose_unit": "mg",
"route": "PR"
},
"s... | [] | 1 | pharmacy_order |
ONCORX-0296 | Infuse Bleomycin 10 units/m2 IV over 60 minutes. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Bleomycin",
"drug_normalized": "Bleomycin",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "10",
"dose_unit": "units/m2",
"route": "IV"
},
"start_cha... | [] | 1 | treatment_plan |
ONCORX-0298 | Oxaliplatin 130 mg/m2 IV q2w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Oxaliplatin",
"drug_normalized": "Oxaliplatin",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "130",
"dose_unit": "mg/m2",
"route": "IV",
"frequency":... | [] | 1 | chemo_order |
ONCORX-0299 | Plan: Etoposide 50 mg/m2 IV days 1-3 q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Etoposide",
"drug_normalized": "Etoposide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "50",
"dose_unit": "mg/m2",
"route": "IV",
"frequency": "day... | [] | 1 | treatment_plan |
ONCORX-0300 | Begin Capecitabine at 1250 mg/m2 PO BID days 1-14 q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Capecitabine",
"drug_normalized": "Capecitabine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1250",
"dose_unit": "mg/m2",
"route": "PO",
"frequenc... | [] | 1 | treatment_plan |
ONCORX-0301 | Patient received Pegfilgrastim 6 mg SC without adverse reaction. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Pegfilgrastim",
"drug_normalized": "Pegfilgrastim",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "6",
"dose_unit": "mg",
"route": "SC"
},
"start_ch... | [] | 1 | chemo_order |
ONCORX-0302 | Trastuzumab 8 mg/kg loading IV q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Trastuzumab",
"drug_normalized": "Trastuzumab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "8",
"dose_unit": "mg/kg loading",
"route": "IV",
"frequ... | [] | 1 | treatment_plan |
ONCORX-0303 | Plan: Gabapentin 100 mg PO q8h. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Gabapentin",
"drug_normalized": "Gabapentin",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "100",
"dose_unit": "mg",
"route": "PO",
"frequency": "q8h... | [] | 1 | pharmacy_order |
ONCORX-0304 | Started Bleomycin 30 units IV per protocol. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Bleomycin",
"drug_normalized": "Bleomycin",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "30",
"dose_unit": "units",
"route": "IV"
},
"start_char":... | [] | 1 | pharmacy_order |
ONCORX-0305 | Begin Decitabine at 20 mg/m2 IV days 1-5 q4w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Decitabine",
"drug_normalized": "Decitabine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "20",
"dose_unit": "mg/m2",
"route": "IV",
"frequency": "d... | [] | 1 | chemo_order |
ONCORX-0306 | Plan: Oxaliplatin 85 mg/m2 IV q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Oxaliplatin",
"drug_normalized": "Oxaliplatin",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "85",
"dose_unit": "mg/m2",
"route": "IV",
"frequency": ... | [] | 1 | chemo_order |
ONCORX-0307 | Pre-medications followed by Sunitinib 50 mg PO. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Sunitinib",
"drug_normalized": "Sunitinib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "50",
"dose_unit": "mg",
"route": "PO"
},
"start_char": 28... | [] | 1 | chemo_order |
ONCORX-0308 | Start Temozolomide 75 mg/m2 PO. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Temozolomide",
"drug_normalized": "Temozolomide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "75",
"dose_unit": "mg/m2",
"route": "PO"
},
"start_... | [] | 1 | pharmacy_order |
ONCORX-0309 | Give Venetoclax 400 mg PO daily. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Venetoclax",
"drug_normalized": "Venetoclax",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "400",
"dose_unit": "mg",
"route": "PO",
"frequency": "dai... | [] | 1 | chemo_order |
ONCORX-0310 | Patient taking Oxycodone 5 mg PO q4-6h at home. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Oxycodone",
"drug_normalized": "Oxycodone",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "5",
"dose_unit": "mg",
"route": "PO",
"frequency": "q4-6h"
... | [] | 1 | chemo_order |
ONCORX-0311 | Morphine 4 mg given IV today. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Morphine",
"drug_normalized": "Morphine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "4",
"dose_unit": "mg",
"route": "IV"
},
"start_char": 0,
... | [] | 1 | chemo_order |
ONCORX-0312 | Pharmacy to dispense Capecitabine 850 mg/m2 for PO administration. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Capecitabine",
"drug_normalized": "Capecitabine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "850",
"dose_unit": "mg/m2",
"route": "PO"
},
"start... | [] | 1 | chemo_order |
ONCORX-0314 | Patient received Diphenhydramine 25 mg IV without adverse reaction. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Diphenhydramine",
"drug_normalized": "Diphenhydramine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "25",
"dose_unit": "mg",
"route": "IV"
},
"sta... | [] | 1 | chemo_order |
ONCORX-0315 | Begin Atezolizumab at 1200 mg IV q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Atezolizumab",
"drug_normalized": "Atezolizumab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1200",
"dose_unit": "mg",
"route": "IV",
"frequency":... | [] | 1 | chemo_order |
ONCORX-0316 | Administer Lenalidomide 15 mg PO. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Lenalidomide",
"drug_normalized": "Lenalidomide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "15",
"dose_unit": "mg",
"route": "PO"
},
"start_cha... | [] | 1 | pharmacy_order |
ONCORX-0317 | Nivolumab 240 mg given IV today. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Nivolumab",
"drug_normalized": "Nivolumab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "240",
"dose_unit": "mg",
"route": "IV"
},
"start_char": 0... | [] | 1 | treatment_plan |
ONCORX-0319 | Patient received Nivolumab 3 mg/kg IV without adverse reaction. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Nivolumab",
"drug_normalized": "Nivolumab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "3",
"dose_unit": "mg/kg",
"route": "IV"
},
"start_char": ... | [] | 1 | treatment_plan |
ONCORX-0320 | Plan: Sorafenib 400 mg PO BID. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Sorafenib",
"drug_normalized": "Sorafenib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "400",
"dose_unit": "mg",
"route": "PO",
"frequency": "BID"
... | [] | 1 | pharmacy_order |
ONCORX-0321 | Pharmacy to dispense Filgrastim 300 mcg for SC administration. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Filgrastim",
"drug_normalized": "Filgrastim",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "300",
"dose_unit": "mcg",
"route": "SC"
},
"start_char"... | [] | 1 | chemo_order |
ONCORX-0322 | Patient taking Fentanyl 50 mcg transdermal q1h at home. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Fentanyl",
"drug_normalized": "Fentanyl",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "50",
"dose_unit": "mcg",
"route": "transdermal",
"frequency":... | [] | 1 | chemo_order |
ONCORX-0324 | Dose: Morphine 15 mg PO. Verify with pharmacy. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Morphine",
"drug_normalized": "Morphine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "15",
"dose_unit": "mg",
"route": "PO"
},
"start_char": 6,
... | [] | 1 | pharmacy_order |
ONCORX-0325 | Infuse Vincristine 2 mg IV over 60 minutes. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Vincristine",
"drug_normalized": "Vincristine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "2",
"dose_unit": "mg",
"route": "IV"
},
"start_char":... | [] | 1 | pharmacy_order |
ONCORX-0326 | Begin Fluorouracil at 400 mg/m2 IV q2w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Fluorouracil",
"drug_normalized": "Fluorouracil",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "400",
"dose_unit": "mg/m2",
"route": "IV",
"frequency... | [] | 1 | pharmacy_order |
ONCORX-0327 | Patient receiving Diphenhydramine 25 mg IV q6h. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Diphenhydramine",
"drug_normalized": "Diphenhydramine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "25",
"dose_unit": "mg",
"route": "IV",
"frequen... | [] | 1 | pharmacy_order |
ONCORX-0328 | Infuse Metoclopramide 10 mg IV over 60 minutes. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Metoclopramide",
"drug_normalized": "Metoclopramide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "10",
"dose_unit": "mg",
"route": "IV"
},
"start... | [] | 1 | treatment_plan |
ONCORX-0329 | Start Rituximab 375 mg/m2 IV. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Rituximab",
"drug_normalized": "Rituximab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "375",
"dose_unit": "mg/m2",
"route": "IV"
},
"start_char"... | [] | 1 | chemo_order |
ONCORX-0330 | Rx: Vincristine 1.4 mg/m2 IV day 1 q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Vincristine",
"drug_normalized": "Vincristine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1.4",
"dose_unit": "mg/m2",
"route": "IV",
"frequency":... | [] | 1 | treatment_plan |
ONCORX-0331 | Started Osimertinib 80 mg PO per protocol. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Osimertinib",
"drug_normalized": "Osimertinib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "80",
"dose_unit": "mg",
"route": "PO"
},
"start_char"... | [] | 1 | pharmacy_order |
ONCORX-0332 | Order: Imatinib 600 mg PO daily. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Imatinib",
"drug_normalized": "Imatinib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "600",
"dose_unit": "mg",
"route": "PO",
"frequency": "daily"
... | [] | 1 | treatment_plan |
ONCORX-0333 | Give Fentanyl 25 mcg IV q1h. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Fentanyl",
"drug_normalized": "Fentanyl",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "25",
"dose_unit": "mcg",
"route": "IV",
"frequency": "q1h"
... | [] | 1 | treatment_plan |
ONCORX-0335 | Ibrutinib 560 mg given PO today. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Ibrutinib",
"drug_normalized": "Ibrutinib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "560",
"dose_unit": "mg",
"route": "PO"
},
"start_char": 0... | [] | 1 | chemo_order |
ONCORX-0336 | Patient receiving Rituximab 375 mg/m2 IV weekly x 4. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Rituximab",
"drug_normalized": "Rituximab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "375",
"dose_unit": "mg/m2",
"route": "IV",
"frequency": "we... | [] | 1 | pharmacy_order |
ONCORX-0337 | Begin Paclitaxel at 135 mg/m2 IV day 1 q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Paclitaxel",
"drug_normalized": "Paclitaxel",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "135",
"dose_unit": "mg/m2",
"route": "IV",
"frequency": "... | [] | 1 | pharmacy_order |
ONCORX-0338 | Start Anastrozole 1 mg PO. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Anastrozole",
"drug_normalized": "Anastrozole",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1",
"dose_unit": "mg",
"route": "PO"
},
"start_char":... | [] | 1 | chemo_order |
ONCORX-0339 | Order: Etoposide 100 mg/m2 IV days 1-5 q3w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Etoposide",
"drug_normalized": "Etoposide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "100",
"dose_unit": "mg/m2",
"route": "IV",
"frequency": "da... | [] | 1 | pharmacy_order |
ONCORX-0340 | Give Bortezomib 1.3 mg/m2 IV days 1,8,15,22 q5w. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Bortezomib",
"drug_normalized": "Bortezomib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1.3",
"dose_unit": "mg/m2",
"route": "IV",
"frequency": "... | [] | 1 | chemo_order |
ONCORX-0341 | Administer Gemcitabine 800 mg/m2 IV. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Gemcitabine",
"drug_normalized": "Gemcitabine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "800",
"dose_unit": "mg/m2",
"route": "IV"
},
"start_c... | [] | 1 | pharmacy_order |
ONCORX-0344 | Start Hydromorphone 1 mg IV. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Hydromorphone",
"drug_normalized": "Hydromorphone",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1",
"dose_unit": "mg",
"route": "IV"
},
"start_ch... | [] | 1 | pharmacy_order |
ONCORX-0345 | Administer Cisplatin 100 mg/m2 IV. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Cisplatin",
"drug_normalized": "Cisplatin",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "100",
"dose_unit": "mg/m2",
"route": "IV"
},
"start_char"... | [] | 1 | pharmacy_order |
ONCORX-0346 | Pre-medications followed by Venetoclax 400 mg PO. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Venetoclax",
"drug_normalized": "Venetoclax",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "400",
"dose_unit": "mg",
"route": "PO"
},
"start_char":... | [] | 1 | pharmacy_order |
ONCORX-0347 | Pharmacy to dispense Loperamide 2 mg for PO administration. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Loperamide",
"drug_normalized": "Loperamide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "2",
"dose_unit": "mg",
"route": "PO"
},
"start_char": 2... | [] | 1 | pharmacy_order |
ONCORX-0348 | Increase Diphenhydramine to 50 mg PO q6h. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Diphenhydramine",
"drug_normalized": "Diphenhydramine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "50",
"dose_unit": "mg",
"route": "PO",
"frequen... | [] | 1 | treatment_plan |
ONCORX-0349 | Pharmacy to dispense Bortezomib 1.3 mg/m2 for IV administration. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Bortezomib",
"drug_normalized": "Bortezomib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "1.3",
"dose_unit": "mg/m2",
"route": "IV"
},
"start_cha... | [] | 1 | treatment_plan |
ONCORX-0350 | Rx: Temozolomide 75 mg/m2 PO daily x 42 days. | C1_CORE_MED_EXTRACTION | C1.2_single_drug_dose | Easy | [
{
"drug_surface": "Temozolomide",
"drug_normalized": "Temozolomide",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"sig": {
"dose_value": "75",
"dose_unit": "mg/m2",
"route": "PO",
"frequency"... | [] | 1 | pharmacy_order |
ONCORX-0351 | Give Decitabine then Cyclophosphamide sequentially. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Decitabine",
"drug_normalized": "Decitabine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 5,
"end_char": 15
},
{
"drug_surface": "Cyclophosphamide",
"drug_normalized... | [] | 2 | treatment_plan |
ONCORX-0352 | The regimen includes Ibuprofen and Paclitaxel. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Ibuprofen",
"drug_normalized": "Ibuprofen",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 21,
"end_char": 30
},
{
"drug_surface": "Paclitaxel",
"drug_normalized": "Pac... | [] | 2 | chemo_order |
ONCORX-0353 | Begin Osimertinib 40 mg PO and Etoposide 100 mg/m2 PO. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Osimertinib",
"drug_normalized": "Osimertinib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 6,
"end_char": 17,
"sig": {
"dose_value": "40",
"dose_unit": "mg",
... | [] | 2 | progress_note |
ONCORX-0357 | Initiate Ibuprofen and Loperamide concurrently. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Ibuprofen",
"drug_normalized": "Ibuprofen",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 9,
"end_char": 18
},
{
"drug_surface": "Loperamide",
"drug_normalized": "Lope... | [] | 2 | chemo_order |
ONCORX-0358 | Rx: Paclitaxel 175 mg/m2 and Nivolumab 3 mg/kg. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Paclitaxel",
"drug_normalized": "Paclitaxel",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 4,
"end_char": 14,
"sig": {
"dose_value": "175",
"dose_unit": "mg/m2"
... | [] | 2 | chemo_order |
ONCORX-0359 | Rx: Prednisone 5 mg and Venetoclax 400 mg. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Prednisone",
"drug_normalized": "Prednisone",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 4,
"end_char": 14,
"sig": {
"dose_value": "5",
"dose_unit": "mg"
}
... | [] | 2 | treatment_plan |
ONCORX-0360 | The patient was started on Pegfilgrastim along with Oxycodone. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Pegfilgrastim",
"drug_normalized": "Pegfilgrastim",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 27,
"end_char": 40
},
{
"drug_surface": "Oxycodone",
"drug_normalized... | [] | 2 | treatment_plan |
ONCORX-0361 | Administer Pegfilgrastim followed by Trastuzumab. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Pegfilgrastim",
"drug_normalized": "Pegfilgrastim",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 11,
"end_char": 24
},
{
"drug_surface": "Trastuzumab",
"drug_normaliz... | [] | 2 | progress_note |
ONCORX-0362 | Rx: Filgrastim 300 mcg and Sorafenib 400 mg. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Filgrastim",
"drug_normalized": "Filgrastim",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 4,
"end_char": 14,
"sig": {
"dose_value": "300",
"dose_unit": "mcg"
... | [] | 2 | progress_note |
ONCORX-0363 | Administer Letrozole followed by Sorafenib. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Letrozole",
"drug_normalized": "Letrozole",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 11,
"end_char": 20
},
{
"drug_surface": "Sorafenib",
"drug_normalized": "Sora... | [] | 2 | treatment_plan |
ONCORX-0364 | Started on Sorafenib 400 mg and Ondansetron 0.15 mg/kg today. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Sorafenib",
"drug_normalized": "Sorafenib",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 11,
"end_char": 20,
"sig": {
"dose_value": "400",
"dose_unit": "mg"
}... | [] | 2 | progress_note |
ONCORX-0365 | Treatment: Ibuprofen and Ondansetron. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Ibuprofen",
"drug_normalized": "Ibuprofen",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 11,
"end_char": 20
},
{
"drug_surface": "Ondansetron",
"drug_normalized": "On... | [] | 2 | chemo_order |
ONCORX-0366 | Treatment: Paclitaxel and Metoclopramide. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Paclitaxel",
"drug_normalized": "Paclitaxel",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 11,
"end_char": 21
},
{
"drug_surface": "Metoclopramide",
"drug_normalized"... | [] | 2 | treatment_plan |
ONCORX-0367 | Rx: Capecitabine 1250 mg/m2 and Vincristine 2 mg. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Capecitabine",
"drug_normalized": "Capecitabine",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 4,
"end_char": 16,
"sig": {
"dose_value": "1250",
"dose_unit": "mg/... | [] | 2 | progress_note |
ONCORX-0368 | Begin Rituximab 375 mg/m2 IV and Cisplatin 75 mg/m2 IV. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Rituximab",
"drug_normalized": "Rituximab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 6,
"end_char": 15,
"sig": {
"dose_value": "375",
"dose_unit": "mg/m2",
... | [] | 2 | chemo_order |
ONCORX-0369 | Acetaminophen and Hydromorphone administered per protocol. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Acetaminophen",
"drug_normalized": "Acetaminophen",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 0,
"end_char": 13
},
{
"drug_surface": "Hydromorphone",
"drug_normali... | [] | 2 | progress_note |
ONCORX-0370 | The regimen includes Acetaminophen and Fentanyl. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Acetaminophen",
"drug_normalized": "Acetaminophen",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 21,
"end_char": 34
},
{
"drug_surface": "Fentanyl",
"drug_normalized"... | [] | 2 | treatment_plan |
ONCORX-0371 | Treatment: Trastuzumab and Capecitabine. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Trastuzumab",
"drug_normalized": "Trastuzumab",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 11,
"end_char": 22
},
{
"drug_surface": "Capecitabine",
"drug_normalized"... | [] | 2 | progress_note |
ONCORX-0372 | Start Methotrexate and Prednisone. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Methotrexate",
"drug_normalized": "Methotrexate",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 6,
"end_char": 18
},
{
"drug_surface": "Prednisone",
"drug_normalized":... | [] | 2 | progress_note |
ONCORX-0373 | Will add Osimertinib to current Hydromorphone. | C1_CORE_MED_EXTRACTION | C1.3_two_drugs | Medium | [
{
"drug_surface": "Hydromorphone",
"drug_normalized": "Hydromorphone",
"status": "current",
"negated": false,
"allergy": false,
"uncertain": false,
"evidence_type": "explicit_surface",
"start_char": 32,
"end_char": 45
},
{
"drug_surface": "Osimertinib",
"drug_normaliz... | [] | 2 | treatment_plan |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.